In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
This flu season, some people will have a choice between getting the standard flu shot or the new mRNA flu vaccine, according ...
The experimental mRNA vaccine successfully cleared phase 3 clinical trials, the last step necessary before it can be approved ...
For older adults, the flu vaccine could look a little different this year.
With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in ...
In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...
A Moderna and Merck mRNA vaccine paired with Keytruda reduced melanoma recurrence or death risk by 49% over five years.